BioDot Journal- The DOT 2026

Building on our legacy. Trailblazing into the future

The Dot 2026 has officially landed, BioDot’s second journal edition and a powerful reflection of where we have been, where we are going, and how precision dispensing continues to shape the future of science.

This edition celebrates more than 30 years of BioDot innovation and customer partnership across lateral flow testing, discovery, diagnostics, automation, and miniaturized liquid handling. Inside, readers will find stories from customers, partners, and BioDot leaders who are advancing real-world applications, from Operon’s long-standing lateral flow development to TECHLAB’s work in in vitro enteric diagnostics, from Rob Rich’s perspective on modular product design to Dr. Hiroki Shigemori and AIST’s work with AD1520™, and from Synevo’s use of CellWriter™ S to our continued focus on NANOlab™ and the future of discovery.

More than a journal, The Dot 2026 is a market-facing story of trust, collaboration, and innovation. It shows how BioDot’s discrete droplet dispensing technologies continue to support customers from research and development through production, helping them improve workflows, scale with confidence, and bring life-changing science closer to the people who need it.

Explore the new edition and see how BioDot is building on its legacy while trailblazing into the next generation of precision dispensing.

‍